Levofloxacin Dosing in Dialysis Patients

Recommended Dosing Strategy

• The American College of Physicians and the Infectious Diseases Society of America recommend administering levofloxacin 750-1000 mg three times per week (every 48-72 hours) to patients with creatinine clearance <30 mL/min or receiving hemodialysis, not daily 1, 2
• For tuberculosis treatment in dialysis patients, the recommended dose is 750-1000 mg per dose, administered three times weekly after dialysis 4, 1, 2
• For other infections in dialysis patients, a 500 mg loading dose, then 250 mg every 48 hours is recommended 5

Key Dosing Principles

• The Infectious Diseases Society of America recommends always administering levofloxacin immediately after hemodialysis on dialysis days to prevent premature drug removal (approximately 24% of the dose is cleared during dialysis) 1, 3

Critical Timing Algorithm

• The American College of Physicians recommends following a specific sequence for levofloxacin administration: administer 500-750 mg immediately after dialysis on Day 0, then administer the next dose after dialysis if dialysis day, or at the same time if non-dialysis day, 48 hours later 1, 5
• Continue this pattern, always timing doses after dialysis when dialysis occurs, to maintain proper 48-72 hour intervals 1, 2

Common Pitfalls to Avoid

• The Infectious Diseases Society of America recommends never administering levofloxacin before dialysis, as this wastes drug and creates subtherapeutic levels immediately post-dialysis, risking treatment failure 1, 3

Monitoring Recommendations

• The National Kidney Foundation recommends considering therapeutic drug monitoring in dialysis patients to ensure adequate drug absorption without excessive accumulation, particularly for patients with borderline renal function requiring dose optimization 1, 3
• Therapeutic drug monitoring is also recommended for patients with additional comorbidities that may affect absorption, such as diabetes with gastroparesis, and for patients on multiple interacting medications 4, 2, 3

Special Considerations

• For peritoneal dialysis patients, the Infectious Diseases Society of America recommends beginning with hemodialysis dosing recommendations and verifying adequacy using serum concentration monitoring 4, 1, 2
• The American Thoracic Society recommends using higher doses (750-1000 mg) for tuberculosis treatment in ESRD, as the fluoroquinolone dosing recommendations from manufacturers may not apply to tuberculosis treatment in this population 4, 2